Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients
Eva Hellström-Lindberg(Karolinska University Hospital), Åke Öst(Synlab Czech (Czechia)), Ingemar Winqvist(Karolinska University Hospital), Eva Löfvenberg(Karolinska University Hospital), Herman Nilsson‐Ehle(Karolinska University Hospital), Jan Carneskog(Karolinska University Hospital), Magnus Carlsson(Karolinska University Hospital), Jon‐Magnus Tangen(Karolinska University Hospital), Lena Kanter‐Lewensohn(Karolinska University Hospital), Tomas Ahlgren(Karolinska University Hospital), Yves Béguin(University of Liège), Anders Österborg(Karolinska University Hospital), Ingunn Dybedal(Karolinska University Hospital), Gunnar Grimfors(Karolinska University Hospital), Gunnar Öberg(Karolinska University Hospital), Olle Linder(Örebro University Hospital), Inger Marie S. Dahl(Karolinska University Hospital), Jan Samuelsson(Karolinska University Hospital), Michaela Luthman(Karolinska University Hospital)
Cited by 306
Related Papers
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
|PubMed|1991|765
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
|New England Journal of Medicine|1997|611
Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis
|Acta Paediatrica|1991|449
Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
|British Journal of Haematology|1997|314
Colonoscopic surveillance in long-standing total ulcerative colitis—A 15-year follow-up study
|Gastroenterology|1990|197